On March 16, 2021, the Turkish Medicine and Medical Devices Authority ("TİTCK") published a document ("Document"), which provides guidance on quality and immunogenicity data that must be submitted...

Through the decision dated 23.06.2020 and numbered 2020/482 ("Decision"), the Personal Data Protection Board has decided to re-extend the registration periods of the Data Controllers Registry...

An accelerated assessment procedure will be applied to applications regarding COVID-19-related clinical trials.

As many competition authorities around the world make announcements on their approach to the global COVID-19 outbreak, we have been waiting to see how the Turkish Competition Authority will respond to the crisis.

The "Pandemic Isolation Tracking Project", which aims to observe the movements of quarantined people and regions, has been announced by the Presidency Of The Republic Of Turkey...

The Turkish Personal Data Protection Authority (DPA) has published its announcement regarding vaccination information and test result applications within the scope of combating COVID-19.

The Personal Data Protection Board (''Board'') has published its decision dated 28.09.2021 and numbered 2021/980 regarding the COVID-19 PCR Test Result and Vaccine Information sharing requests.

The European Data Protection Board (EDPB) has adopted a statement regarding processing of personal data in the context of the COVID-19 outbreak on 19 March 2020.

The President of Turkey, Recep Tayyip Erdoğan, delivered a speech on March 27, 2020 regarding the COVID-19 pandemic, announcing the additional measures the government will undertake in the fight against the pandemic.

A "Public Announcement on Covid-19 PCR Test Result and Vaccine Information Applications" has been published by Personal Data Protection Board on 28.09.2021.

On April 9, 2020, the Personal Data Protection Authority ("DPA") issued an announcement on the processing of location data and mobility tracking during the COVID-19 outbreak.

Due to COVID-19 pandemic, precautions needed to be taken in the field of clinical trials where it is requisite to ensure the protection of the rights, safety and wellbeing of trial participants.

In the current COVID-19 crisis medical device companies continue to prove support to healthcare professionals, healthcare organizations, healthcare systems and governments in order to fulfill the urgent needs.

Turkey - New measures for combating coronavirus announced by the President on 30 November 2020

Several Chambers of Commerce's throughout Turkey published a uniform announcement regarding dividend distributions on their websites, based on the information note of Turkish Union of Chambers and Commodity Exchanges ...

Security Forces enforce public health orders to fight against the counterfeit, unauthorized, unhealthy disinfectants, colognes, masks and sanitary products produced and sold due to COVID-19 pandemic...

Gradually leaving off the disruption in global health behind, we are all getting ready to contemplate how to cope with the prominent economic fragility emerging post Covid-19.

The Turkish Medicine and Medical Devices Authority ("TİTCK") announced that it officially became a regulatory member of the International Council for Harmonization of Technical Requirements for...

In accordance with paragraph 6 of article 6 of the Law on Personal Data Protection, public institutions and organizations may need to collect and share personal data to combat serious threats to public health.

Türkiye İlaç ve Tıbbi Cihaz Kurumu ("Kurum"), Uluslararası Uyum Konseyine (The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use...